Big Pharma Earnings Watch: Astrazeneca

Another Brand Name Drug Maker Beats Expectations After Raising Prices

Rounding out this week’s reporting on third quarter earnings, Big Pharma giant AstraZeneca joined four other brand name giants in beating expectations after raising prices on their products earlier this year.

AstraZeneca has a history of hiking prices on Americans struggling to afford their medications:
So far, brand name Big Pharma giants, including Eli Lilly, Johnson & Johnson, Roche and Novartis, have run the table on Q3 earnings expectations after continuing to hike prices on their brand name drugs.

Stay tuned next week to see if Amgen, Merck, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Sanofi and AbbVie, will continue the trend.


Sign-up for updates

  • This field is for validation purposes and should be left unchanged.